Incident Overview:
- NAFDAC notifies the public of a recall for one lot of Benylin Paediatric Syrup by Johnson & Johnson.
- Recent laboratory analysis found an unacceptable high level of Diethylene glycol in the product.
- The syrup is indicated for cough relief and treatment of allergic conditions in children aged 2 to 12 years.
- Diethylene glycol is toxic to humans and can cause severe symptoms including abdominal pain, vomiting, altered mental state, and acute kidney injury.
- Consumers are urged to discontinue use of the affected lot and seek medical attention if experiencing adverse effects.
Authorities Response:
NAFDAC implores importers, distributors, retailers and consumers to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale and use of the substandard (contaminated) regulated products. All medical products must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked.
Societies Duty:
- Consumers are instructed to discontinue sale or use of the recalled Benylin Paediatric Syrup and submit stock to the nearest NAFDAC office.
- Any adverse reactions experienced after using the product should prompt immediate medical attention from a qualified healthcare professional.
- Healthcare professionals and consumers should report suspicions of substandard and falsified medicines to NAFDAC through various channels, including phone (0800-162-3322) or email (sf.alert@nafdac.gov.ng).
- Additionally, adverse events or side effects related to the use of the product should be reported to the nearest NAFDAC office.
Conclusion: In conclusion, the recall of Benylin Paediatric Syrup underscores the critical importance of rigorous quality control measures in the pharmaceutical industry. NAFDAC’s swift action in response to the detection of Diethylene glycol highlights their commitment to ensuring public safety and health. Consumers and healthcare professionals play vital roles in this process by promptly reporting any adverse reactions or suspicions of substandard medicines. This incident serves as a reminder of the ongoing need for vigilant monitoring and regulation to safeguard the well-being of individuals who rely on medicinal products for their health.
To read more on this article: https://childreninfobank.com/safebank/public-alert-no-013-2024-alert-on-recall-of-benylin-paediatrics-syrup-in-nigeria/
Source of Image: Nafdac Website